Effects of ezetimibe/simvastatin compared to simvastatin monotherapy in reducing C-reactive protein and low density lipoprotein-cholesterol

被引：0
|
作者：
Ballantyne, CM
Ridker, P
Pearson, T
Veltri, E
Mitchel, YB
Sisk, CMM
Shah, AK
Maccubbin, DL
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：316A / 316A
页数：1
相关论文
共 50 条
  • [41] Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients
    Farnier, Michel
    Taggart, William
    Dong, Qian
    Lin, Jianxin
    Shah, Arvind
    Brudi, Philippe
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (03) : 179 - 187
  • [42] Evaluation of ezetimibe/simvastatin versus atorvastatin on high-sensitivity C-reactive protein (Hs-CRP)
    King, T
    Ballantyne, CM
    Abate, N
    Yuan, Z
    Palmisano, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 111 - 111
  • [43] Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia
    Kostakou, Peggy
    Kolovou, Genovefa
    Anagnostopoulou, Katherine
    Theodoridis, Theodor
    Galea, Vassiliki
    Mihas, Constantinos
    Christopoulou-Cokkinou, Vassiliki
    Cokkinos, Dennis V.
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (01) : 26 - 32
  • [44] Effect of withdrawal of Pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol
    van der Harst, Pim
    Asselbergs, Folkert W.
    Hillege, Hans L.
    Bakker, Stephan J. L.
    Voors, Adriaan A.
    van Veldhuisen, Dirk J.
    van Gilst, Wiek H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (10): : 1548 - 1551
  • [45] Preventive cardiology: Move over low density lipoprotein cholesterol, hello C-reactive protein?
    Genest, J
    CANADIAN JOURNAL OF CARDIOLOGY, 2004, 20 : 89B - 92B
  • [46] A Population Pharmacokinetic-Pharmacodynamic Model for Simvastatin that Predicts Low-Density Lipoprotein-Cholesterol Reduction in Patients with Primary Hyperlipidaemia
    Kim, Jimyon
    Ahn, Byung-Jin
    Chae, Hong-Seok
    Han, Seunghoon
    Doh, Kichan
    Choi, Jeongeun
    Jun, Yong K.
    Lee, Yong W.
    Yim, Dong-Seok
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (03) : 156 - 163
  • [47] Effect of splitting simvastatin tablets for control of low-density lipoprotein cholesterol
    Parra, D
    Beckey, NP
    Raval, HS
    Schnacky, KR
    Calabrese, V
    Coakley, RW
    Goodhope, RC
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (12): : 1481 - 1483
  • [48] Effect of pravastatin-to-simvastatin conversion on low-density-lipoprotein cholesterol
    Ito, MK
    Lin, JC
    Morreale, AP
    Marcus, DB
    Shabetai, R
    Dresselhaus, TR
    Henry, RR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (18) : 1734 - 1739
  • [49] Low density lipoprotein lowering efficacy of the ezetimibe/simvastatin combination tablet in a large cohort of women
    Gallup, E
    Colleran, K
    Goldberg, A
    Davidson, M
    Shah, A
    Maccubbin, D
    Donahue, S
    Veltri, E
    Mitchel, Y
    CIRCULATION, 2005, 111 (04) : E52 - E53
  • [50] Effects of Ezetimibe Plus Moderate-Dose Simvastatin Versus Higher-Dose Simvastatin Alone on C-Reactive Protein and Platelet Function in Patients With Stable Coronary Artery Disease
    Pesaro, Antonio E. P.
    Serrano, Carlos V., Jr.
    Martins, Herlon Saraiva
    De Lemos, James
    Parra, Paulo R.
    Fernandes, Juliano L.
    Ladeira, Renata T.
    Giraldez, Roberto Rocha C. V.
    Nicolau, Jose Carlos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A343 - A343
12345